Join
Live feed
·
PRReleasevia Quantisnow
Immunomedics, Inc. logo

ProteoNic Announces Licensing of Technology for Production of Biologics to Immunomedics

ByQuantisnow·Wall Street's wire, on your screen.
IMMU· Immunomedics, Inc.
Health Care
Full content unavailable. See the original source below.
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IMMU (Immunomedics, Inc.) and more on Quantisnow.